Top Institutions in Ophthalmology - Myopia Management
Institutions were ranked based on their known leadership in myopia research, clinical trials on specialty lenses and atropine therapy, development of novel optical devices, and contributions to understanding myopia progression and control strategies.
-
#1
The Hong Kong Polytechnic University
Hong Kong, N/A
Renowned for pioneering research in myopia control, especially in specialty contact lens design and clinical trials on orthokeratology and multifocal lenses. The institution has a strong focus on innovative optical interventions and combination therapies.
Key Differentiators
- Ophthalmology
- Vision Science
- Myopia Research
-
#2
University of California, Berkeley
Berkeley, CA
Strong interdisciplinary research combining ophthalmology and engineering to develop smart contact lenses and biosensor technologies. Significant contributions to understanding myopia progression and novel therapeutic approaches.
Key Differentiators
- Ophthalmology
- Vision Science
- Biomedical Engineering
-
#3
University of Sydney
Sydney, NSW
Internationally recognized for clinical research in myopia management, including atropine therapy and optical interventions. Pioneered studies on combination therapies and spectacle lens designs for myopia control.
Key Differentiators
- Ophthalmology
- Optometry
- Myopia Control
-
#4
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Leading clinical and translational research in pediatric myopia management, including pharmacologic and optical interventions. Strong focus on integrating new technologies into clinical practice.
Key Differentiators
- Ophthalmology
- Pediatric Ophthalmology
- Vision Research
-
#5
Singapore National Eye Centre
Singapore, N/A
Extensive clinical research on myopia prevalence and control strategies in Asian populations. Active in evaluating new optical and pharmacologic interventions and their long-term outcomes.
Key Differentiators
- Ophthalmology
- Myopia Research
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


